Quintiles Seminar Series
    Pinar Karaca Mandic


    Seminar Topic: The Effect of The Risk Corridors Program on Marketplace Premiums and Participation

    Pinar Karaca Mandic
    Associate Professor, Finance
    Carlson School of Management at the University of Minnesota

    Tuesday | February 6, 2018 2:00 PM-3:30 PM
    University of Southern California
    Verna and Peter Dauterive Hall (VPD) 116

    About Pinar Karaca Mandic
    Associate Professor Pinar Karaca-Mandic teaches healthcare marketplace and healthcare finance. She is the Academic Director of the Medical Industry Leadership Institute (MILI) in the Department of Finance. 

    She is a Research Associate at the National Bureau of Economic Research (NBER), in Health Economics and Healthcare programs. She also serves as an Associate Editor of Forum for Health Economics and Policy, and an Editorial Board Member for the International Journal of Health Economics and Management. She represents the University of Minnesota in the Health Care Cost Institute’s Academic Advisory Panel.

    Her research focuses on health insurance benefit design, healthcare regulations, insurance markets, pharmaceutical use, and medical technology diffusion. Dr. Karaca-Mandic’s research has been published in leading economics, medical and health policy journals including the Journal of Political Economy, Journal of Risk and Insurance, Journal of Health Economics, Journal of the American Medical Association (JAMA), British Medical Journal, Health Services Research and Health Affairs. Her research has been funded by the National Institutes of Health (NIH), the Agency for Healthcare Research and Quality (AHRQ), The U.S. Department of Health and Human Services, Health Resources and Services Administration, and the Robert Wood Johnson Foundation. She recently completed an NIH funded career grant through which she has been building a research agenda focused on understanding the mechanisms underlying the diffusion of new medical technologies. She is currently the Principal Investigator on NIH and AHRQ funded projects to study uptake of clinical evidence by providers focusing on de-adoption of treatments that are shown to be ineffective or harmful.
    Prior to joining the Carlson School faculty, Karaca-Mandic was Associate Professor of Health Policy and Management at the University of Minnesota’s School of Public Health.